Literature DB >> 15362491

Momordica charantia fruit juice stimulates glucose and amino acid uptakes in L6 myotubes.

E Cummings1, H S Hundal, H Wackerhage, M Hope, M Belle, E Adeghate, J Singh.   

Abstract

The fruit of Momordica charantia (family: Cucurbitacea) is used widely as a hypoglycaemic agent to treat diabetes mellitus (DM). The mechanism of the hypoglycaemic action of M. charantia in vitro is not fully understood. This study investigated the effect of M. charantia juice on either 3H-2-deoxyglucose or N-methyl-amino-a-isobutyric acid (14C-Me-AIB) uptake in L6 rat muscle cells cultured to the myotube stage. The fresh juice was centrifuged at 5000 rpm and the supernatant lyophilised. L6 myotubes were incubated with either insulin (100 nM), different concentrations (1-10 microg ml(-1)) of the juice or its chloroform extract or wortmannin (100 nM) over a period of 1- 6 h. The results were expressed as pmol min(-1) (mg cell protein)(-1), n = 6-8 for each value. Basal 3H-deoxyglucose and 14C-Me-AIB uptakes by L6 myotubes after 1 h of incubation were (means +/- S.E.M.) 32.14 +/- 1.34 and 13.48 +/- 1.86 pmol min(-1) (mg cell protein)(-1), respectively. Incubation of L6 myotubes with 100 nM insulin for 1 h resulted in significant (ANOVA, p < 0.05) increases in 3H-deoxyglucose and 14C-Me-AIB uptakes. Typically, 3H-deoxyglucose and 14C-Me-AIB uptakes in the presence of insulin were 58.57 +/- 4.49 and 29.52 +/- 3.41 pmol min(-1) (mg cell protein(-1)), respectively. Incubation of L6 myotubes with three different concentrations (1, 5 and 10 microg ml(-1)) of either the lyophilised juice or its chloroform extract resulted in time-dependent increases in 3H-deoxy-D-glucose and 14C-Me-AIB uptakes, with maximal uptakes occurring at a concentration of 5 microg ml(-1). Incubation of either insulin or the juice in the presence of wortmannin (a phosphatidylinositol 3-kinase inhibitor) resulted in a marked inhibition of 3H-deoxyglucose by L6 myotubes compared to the uptake obtained with either insulin or the juice alone. The results indicate that M. charantia fruit juice acts like insulin to exert its hypoglycaemic effect and moreover, it can stimulate amino acid uptake into skeletal muscle cells just like insulin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15362491     DOI: 10.1023/b:mcbi.0000028743.75669.ab

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  13 in total

1.  Clinical trial in patients with diabetes mellitus of an insulin-like compound obtained from plant source.

Authors:  V S Baldwa; C M Bhandari; A Pangaria; R K Goyal
Journal:  Ups J Med Sci       Date:  1977       Impact factor: 2.384

2.  The rising global burden of diabetes and its complications: estimates and projections to the year 2010.

Authors:  A F Amos; D J McCarty; P Zimmet
Journal:  Diabet Med       Date:  1997       Impact factor: 4.359

Review 3.  Plant foods in the management of diabetes mellitus: vegetables as potential hypoglycaemic agents.

Authors:  K Platel; K Srinivasan
Journal:  Nahrung       Date:  1997-04

Review 4.  Global and societal implications of the diabetes epidemic.

Authors:  P Zimmet; K G Alberti; J Shaw
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

5.  Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat.

Authors:  I Ahmed; E Adeghate; A K Sharma; D J Pallot; J Singh
Journal:  Diabetes Res Clin Pract       Date:  1998-06       Impact factor: 5.602

6.  Additive effects of prior exercise and insulin on glucose and AIB uptake by rat muscle.

Authors:  A Zorzano; T W Balon; M N Goodman; N B Ruderman
Journal:  Am J Physiol       Date:  1986-07

7.  Regulation of amino acid transport in L6 myoblasts. II. Different chemical properties of transport after amino acid deprivation.

Authors:  A Klip; W J Logan; E Gagalang
Journal:  J Cell Physiol       Date:  1982-10       Impact factor: 6.384

8.  Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes.

Authors:  J Welihinda; E H Karunanayake; M H Sheriff; K S Jayasinghe
Journal:  J Ethnopharmacol       Date:  1986-09       Impact factor: 4.360

9.  Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells.

Authors:  T Tsakiridis; H E McDowell; T Walker; C P Downes; H S Hundal; M Vranic; A Klip
Journal:  Endocrinology       Date:  1995-10       Impact factor: 4.736

10.  Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells.

Authors:  H S Hundal; T Ramlal; R Reyes; L A Leiter; A Klip
Journal:  Endocrinology       Date:  1992-09       Impact factor: 4.736

View more
  18 in total

1.  Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice.

Authors:  Zhong Q Wang; Xian H Zhang; Yongmei Yu; Alexander Poulev; David Ribnicky; Z Elizabeth Floyd; William T Cefalu
Journal:  J Nutr Biochem       Date:  2011-01-28       Impact factor: 6.048

2.  Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats.

Authors:  A K Shetty; G Suresh Kumar; K Sambaiah; P V Salimath
Journal:  Plant Foods Hum Nutr       Date:  2005-09       Impact factor: 3.921

Review 3.  Impact of dietary polyphenols on carbohydrate metabolism.

Authors:  Kati Hanhineva; Riitta Törrönen; Isabel Bondia-Pons; Jenna Pekkinen; Marjukka Kolehmainen; Hannu Mykkänen; Kaisa Poutanen
Journal:  Int J Mol Sci       Date:  2010-03-31       Impact factor: 5.923

Review 4.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

5.  Medicinal chemistry of the anti-diabetic effects of momordica charantia: active constituents and modes of actions.

Authors:  Jaipaul Singh; Emmanuel Cumming; Gunasekar Manoharan; Huba Kalasz; Ernest Adeghate
Journal:  Open Med Chem J       Date:  2011-09-09

6.  Medicinal chemistry of novel anti-diabetic drugs.

Authors:  Ernest Adeghate
Journal:  Open Med Chem J       Date:  2011-09-09

7.  Binding Energy calculation of GSK-3 protein of Human against some anti-diabetic compounds of Momordica charantia linn (Bitter melon).

Authors:  Ridip Hazarika; Pratap Parida; Bijoy Neog; Raj Narain Singh Yadav
Journal:  Bioinformation       Date:  2012-03-31

8.  Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus.

Authors:  Cheryl A Lans
Journal:  J Ethnobiol Ethnomed       Date:  2006-10-13       Impact factor: 2.733

9.  Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.

Authors:  Rooh Ullah Khan; Mohammad Bashir
Journal:  Nutr J       Date:  2015-01-26       Impact factor: 3.271

10.  Natural Compound 3β,7β,25-trihydroxycucurbita-5,23(E)-dien-19-al from Momordica charantia Acts as PPARγ Ligand.

Authors:  Nur Adelina Ahmad Noruddin; Mohamad Faiz Hamzah; Zulfadli Rosman; Nurul Hanim Salin; Alexander Chong Shu-Chien; Tengku Sifzizul Tengku Muhammad
Journal:  Molecules       Date:  2021-05-03       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.